Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Publications

Liang, Wenhua, Jiaxi He, Yaxing Shen, Jianfei Shen, Qihua He, Jianrong Zhang, Gening Jiang, et al. “Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 11 (April 2017): 1162–70. https://doi.org/10.1200/jco.2016.67.5140.

Full Text

Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica Bauman, Lucian R. Chirieac, Thomas A. D’Amico, et al. “Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.” Journal of the National Comprehensive Cancer Network : Jnccn 15, no. 4 (April 2017): 504–35. https://doi.org/10.6004/jnccn.2017.0050.

Full Text

Cox, Morgan L., Chi-Fu Jeffrey Yang, Paul J. Speicher, Kevin L. Anderson, Zachary W. Fitch, Lin Gu, Robert Patrick Davis, et al. “The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.” J Thorac Oncol 12, no. 4 (April 2017): 689–96. https://doi.org/10.1016/j.jtho.2017.01.003.

Full Text

Speicher, Paul J., Brian R. Englum, Asvin M. Ganapathi, Xiaofei Wang, Matthew G. Hartwig, Thomas A. D’Amico, and Mark F. Berry. “Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.” Annals of Surgery 265, no. 4 (April 2017): 743–49. https://doi.org/10.1097/sla.0000000000001702.

Full Text

Yi, John, Jeffrey Melson Clarke, Patrick Healy, Xiaofei F. Wang, Debra Shoemaker, Mark W. Onaitis, Chelsae Dumbauld, et al. “Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).” In Journal of Clinical Oncology, 35:26–26. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.7_suppl.26.

Full Text

Pedersen, Jesper Holst, Witold Rzyman, Giulia Veronesi, Thomas A. D’Amico, Paul Van Schil, Laureano Molins, Gilbert Massard, and Gaetano Rocco. “Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.” Eur J Cardiothorac Surg 51, no. 3 (March 1, 2017): 411–20. https://doi.org/10.1093/ejcts/ezw418.

Full Text

Landreneau, Rodney J., Thomas A. D’Amico, Matt J. Schuchert, and Scott J. Swanson. “Segmentectomy and Lung Cancer: Why, When, How, and How Good?” Seminars in Thoracic and Cardiovascular Surgery 29, no. 1 (March 2017): 119–28. https://doi.org/10.1053/j.semtcvs.2017.04.003.

Full Text

Pages